Status:

COMPLETED

Factors Influencing the Mortality of Patients With Subarachnoid Haemorrhage

Lead Sponsor:

Melike Cengiz

Conditions:

Spontaneous Subarachnoid Hemorrhage

Eligibility:

All Genders

18+ years

Brief Summary

Spontaneous subarachnoid haemorrhage (SAH) is a serious cerebrovascular disease with high morbidity and mortality.Determining the factors associated with mortality in the ICU follow-up and treatment o...

Detailed Description

Patients aged 18 years and older who were diagnosis of spontaneous SAH and admitted the ICU were included in the study. The diagnosis of spontaneous SAH was based on the brain computed tomography (CT)...

Eligibility Criteria

Inclusion

  • Patients aged ≥18 years with a confrmed diagnosis of spontaneous subarachnoid haemorrhage by a brain computed tomography (CT)
  • Patients with a final outcome (survival or mortality) in our centre

Exclusion

  • Patients with traumatic SAH
  • History of significant head trauma in the previous two weeks (any abnormality on brain CT requiring hospitalisation for more than 24 hours)
  • Pregnancy
  • Length of intensive care unit stay ≤24 hours

Key Trial Info

Start Date :

March 1 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 15 2024

Estimated Enrollment :

117 Patients enrolled

Trial Details

Trial ID

NCT06490640

Start Date

March 1 2024

End Date

June 15 2024

Last Update

July 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey

Antalya, Turkey (Türkiye)